Equillium Inc (EQ)
0.6458
+0.05
(+7.99%)
USD |
NASDAQ |
Dec 24, 16:00
Equillium Cash from Investing (Quarterly): 12.00M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Matinas BioPharma Holdings Inc | 9.646M |
| Tenon Medical Inc | -0.104M |
| Alphatec Holdings Inc | -19.88M |
| Madrigal Pharmaceuticals Inc | -202.39M |
| Spero Therapeutics Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.657M |
| Free Cash Flow | -21.51M |
| Free Cash Flow Per Share (Quarterly) | -0.2162 |
| Free Cash Flow to Equity (Quarterly) | -7.657M |
| Free Cash Flow to Firm (Quarterly) | -7.657M |
| Free Cash Flow Yield | -93.53% |